Position in VNDA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$9,080,776
-$890,112 QoQ
Shares Held
1,483,787
+2.8% QoQ
Ownership
2.45%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 172 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. VNDA ranks #198 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in VNDA
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,080,776 | 1,483,787 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $9,970,888 | 1,442,965 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $12,275,586 | 1,391,790 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $6,946,504 | 1,392,085 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $7,984,530 | 1,691,638 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $7,406,611 | 1,613,641 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $6,946,984 | 1,450,310 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $6,687,128 | 1,425,827 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $7,519,906 | 1,330,957 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $5,118,520 | 1,245,382 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $5,256,022 | 1,245,503 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $5,094,381 | 1,179,255 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $7,479,149 | 1,134,924 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $7,350,385 | 1,082,531 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,778,640 | 1,052,590 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $10,141,948 | 1,026,513 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $11,087,131 | 1,017,168 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $11,450,707 | 1,012,441 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $16,117,678 | 1,027,258 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $17,323,466 | 1,010,704 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 ALXN | — | 4,145,346 | Shares | Defined | 2021-08-13 | |
| 2021-06-30 | $21,603,826 | 1,004,362 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 ALXN | — | 3,969,950 | Shares | Defined | 2021-05-12 | |
| 2021-03-31 | $14,500,518 | 965,414 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 ALXN | — | 3,843,989 | Shares | Defined | 2021-02-12 | |
| 2020-12-31 | $11,187,697 | 851,423 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 ALXN | — | 3,788,709 | Shares | Defined | 2020-11-13 | |
| 2020-09-30 | $7,900,353 | 817,842 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 ALXN | — | 3,791,119 | Shares | Defined | 2020-08-13 | |
| 2020-06-30 | $9,219,701 | 805,918 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 ALXN | — | 3,270,353 | Shares | Defined | 2020-05-14 | |
| 2020-03-31 | $7,896,651 | 762,225 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||